Drugmaker Eli Lilly announces new plant in Pennsylvania as part of broader domestic expansion
Drugmaker Eli Lilly and Co. said that it will build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands domestic production and capitalizes on surging sales of obesity and diabetes treatments.










